D

Aclaris Therapeutics, Inc. ACRS

NASDAQ
Recommendation
Dividend Power Score
Day's Range
$3.40$3.55
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
My Lists My Alerts

09/30/2026 06/30/2026
Revenue -9.09% -18.39%
Total Other Revenue -- --
Total Revenue -9.09% -18.39%
Cost of Revenue -10.92% 11.89%
Gross Profit 11.09% -15.80%
SG&A Expenses -0.17% -10.31%
Depreciation & Amortization -- --
Other Operating Expenses -- --
Total Operating Expenses -8.38% 5.70%
Operating Income 8.33% -7.87%
Income Before Tax 13.93% -8.48%
Income Tax Expenses -- --
Earnings from Continuing Operations 13.93% -8.48%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income 13.93% -8.48%
EBIT 8.33% -7.87%
EBITDA -- -7.87%
EPS Basic 17.78% 2.08%
Normalized Basic EPS 13.99% 3.43%
EPS Diluted 17.78% 2.08%
Normalized Diluted EPS 13.99% 3.43%
Average Basic Shares Outstanding 4.70% 10.81%
Average Diluted Shares Outstanding 4.70% 10.81%
Dividend Per Share -- --
Payout Ratio -- --